12/2
09:29 am
sprc
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
Medium
Report
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
12/1
08:32 am
sprc
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
High
Report
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
11/26
10:31 am
sprc
CNN values your feedback [CNN]
High
Report
CNN values your feedback [CNN]
11/26
08:28 am
sprc
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems [Yahoo! Finance]
High
Report
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems [Yahoo! Finance]
11/26
07:38 am
sprc
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
High
Report
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
11/20
06:42 am
sprc
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
High
Report
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
11/19
07:04 pm
sprc
Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression [Yahoo! Finance]
Medium
Report
Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression [Yahoo! Finance]
10/24
07:55 am
sprc
SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio
Low
Report
SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio
10/23
04:03 pm
sprc
SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Low
Report
SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
10/23
08:55 am
sprc
SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery
High
Report
SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery
10/20
07:41 am
sprc
SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
High
Report
SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
10/15
07:05 am
sprc
SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio
Medium
Report
SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio
10/6
09:50 am
sprc
SciSparc And AutoMax Call Off Merger [Yahoo! Finance]
Medium
Report
SciSparc And AutoMax Call Off Merger [Yahoo! Finance]
10/6
06:50 am
sprc
SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors [Yahoo! Finance]
Medium
Report
SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors [Yahoo! Finance]
10/6
06:40 am
sprc
SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors
Medium
Report
SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors
9/29
04:28 pm
sprc
SciSparc's subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29% [Seeking Alpha]
Medium
Report
SciSparc's subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29% [Seeking Alpha]
9/29
04:03 pm
sprc
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
High
Report
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
9/25
04:07 pm
sprc
N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer [Yahoo! Finance]
High
Report
N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer [Yahoo! Finance]
9/25
07:35 am
sprc
SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery [Yahoo! Finance]
High
Report
SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery [Yahoo! Finance]
9/25
07:05 am
sprc
SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery
High
Report
SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery